DEFINITIVE CONTRACT
Active75F40126C00153
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$540.9K
obligated · signed 7 days ago
EO 14398 - DEVELOPING REGULATORY SCIENCE TOOLS FOR ORAL PEPTIDE DELIVERY: INTEGRATING MECHANISTIC UNDERSTANDING WITH PREDICTIVE IN VITRO MODELS. (BAA# FY26C1CP7)
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
PURDUE UNIVERSITY
Contract 75F40126C00153
UEI
YRXVL4JYCEF5
Parent Company
PURDUE UNIVERSITY
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$540,907
Base + Exercised Options
$540,907
Total Ceiling Value
$540,907
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.